5 reasons why quality management needs a GxP-regulated cloud

The global shift from traditional IT offerings to cloud services continues

picture of

Breaking News

PCI announces new facility dedicated to clinical trial returns

Continued investment at Bridgend site enables capacity expansion for segregated space in support of the return of ...

Recipharm releases first serialised products to Europe

Recipharm, a leading contract development and manufacturing organisation (CDMO), has released its first serialised ...

To comply with EU FMD Fareva selects TraceLink

The API CDMO has selected the track and trace network provider, so that it can successfully connect with its ...

Preparing PIs for post EU-FMD success

Ian Haynes of Excellis Europe explains how the companyís unique approach to enabling collaboration between parallel ...

PCI completes acquisition of Sherpa Clinical Packaging

The acquisition enhances PCIís portfolio of molecule-to-market capabilities, adding sterile and non-sterile drug ...

First prescription CBD from GW Pharma has restriction lowered

The US Drug Enforcement Administrationís decision to move Epidiolex to Schedule V was based on non-clinical and ...

Serialisation and data connectivity: Part I

The new wrinkle in your supply chain

Patients could lose out on life-saving treatments

Limited access to novel therapies could hinder effective personalised cancer treatment in the UK, says GlobalData

RFXCEL launches FMD compliance solution for pharmacy workflow

The new software has been adapted to build a workflow designed to enable dispensers to manage split packs, aggregation ...

The Falsified Medicines Directive: clarification for wholesalers, distributors and logistics partners

The Falsified Medicines Directive (FMD) 2011/62/EU comes into force on 9 February 2019

Discover, learn and connect at Lab Innovations!

Experience the latest developments at the UKís only event dedicated to the laboratory industry

Why risk it? FMD is not going away! Are you ready?

The Falsified Medicines Directive (FMD) imposes strict serialisation requirements on pharmaceutical manufacturers, ...

Impact of trade agreements and regulatory divergence

CPhI Annual Report warns trade and patent changes could increase healthcare cost by $100bn in the next 5 years

Further development of CAR-T cell therapy requires industry input

Academic institutions globally are turning to immuno-oncology research to improve outcomes for young patients suffering ...